The features selection algorithm identified line of treatment, histotype, IHC PDL1 (binarized < 25% versus ≥ 25%), ECOG PS, anemia, thrombosis before therapy, NLR, LDH, metastases sites, and ACCI as the most informative subset of predictors of the outcome. This evidence concerns the gene CD274 and Venous thrombosis.